Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

Under the concept of Smart Agriculture, its subsidiary… imports & distributes a wide range of advanced agro-machinery, including several models of automatic paddy threshing machines black-seed removal ...